News Exclusive Trial to extend breast cancer screening won’t resume randomisation after pandemic BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3337 (Published 26 August 2020) Cite this as: BMJ 2020;370:m3337 Article Related content Metrics Responses Peer review Related articles Analysis Cost of extending the NHS breast screening age range in England Published: 10 April 2019; BMJ 365 doi:10.1136/bmj.l1293 See more US women must be told breast density after mammogram, says FDA BMJ September 18, 2024, 386 q2045; DOI: https://doi.org/10.1136/bmj.q2045 Government considers outdoor smoking ban in England BMJ August 30, 2024, 386 q1908; DOI: https://doi.org/10.1136/bmj.q1908 US spends $43bn a year on cancer screening BMJ August 12, 2024, 386 q1787; DOI: https://doi.org/10.1136/bmj.q1787 Johnson & Johnson pays $700m to 42 US states to settle Baby Powder asbestos claims BMJ June 26, 2024, 385 q1425; DOI: https://doi.org/10.1136/bmj.q1425 Lib Dems launch “manifesto to save NHS” with pledges on GP access and cancer BMJ June 11, 2024, 385 q1288; DOI: https://doi.org/10.1136/bmj.q1288
